Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002187 · ClinicalTrials.gov registry record · NA
A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
A NA study, sponsored by Ionis Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
NCT00002187: Completed NA study, sponsored by Ionis Pharmaceuticals.
NCT00002187 is a NA study that has completed, run by Ionis Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002187, a NA study, has completed, sponsored by Ionis Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to compare the safety and effectiveness of two dosage schedules for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis
Interventions
- DRUG Fomivirsen sodium
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002187 record still lists
NCT00002187 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Fomivirsen sodium is the first listed.
NCT00002187 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002187 about?
NCT00002187 is a clinical study titled "A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis". The purpose of this study is to compare the safety and effectiveness of two dosage schedules for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis
What is the current status of trial NCT00002187?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002187?
The interventions under investigation include: Fomivirsen sodium (DRUG).
Who is sponsoring clinical trial NCT00002187?
This trial is sponsored by Ionis Pharmaceuticals, which has 76 total clinical trials registered on ClinicalTrials.gov.